BioStar Capital

About BioStar Capital

BioStar Capital is a visionary healthcare investment firm based in the United States, focused on value-add investments in transformational medical technologies. Their unique strategy aims to produce life-changing outcomes for patients and rewarding returns for investors through a collaboration of renowned healthcare clinicians, executives, medical thought leaders, and financial professionals.

Products & Services

Investment in Medical Technologies:BioStar Capital invests in innovative medical technologies with a focus on transformational impact, having been at the forefront of such opportunities for over two decades.

Specialties

Transformational Medical Technologies Robotic Microsurgery Clinical Expertise Business Acumen in Healthcare

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Capital Fund T: - FT: Venture Capital Fund	A: 130300000 MR: - FA: $130.3 million FAN: 130300000	D: 2023-12-06 FD: 2023-12-06	-

Venture Capital Fund Latest

2023-12-06

$130.3M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Louis Cannon

Founder, Senior Managing Director

M

Mark Toland

Managing Director

B

Ben Cannon

Growth Equity, Partner & Advisor

A

Alan Davis

Managing Director

S

Steven Yakubov

Director

S

Steve Bonelli

CFO

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

BioStar Capital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised